Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Talaris Therapeutics (TALS) Insider Trading & Ownership

Talaris Therapeutics logo

Talaris Therapeutics (NASDAQ:TALS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.50%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$383,766.22
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$2.18 M
Get TALS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Talaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TALS Insider Buying and Selling by Quarter

Talaris Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2023Suzanne IldstadDirectorSell12,942$2.49$32,225.58  
6/12/2023Suzanne IldstadDirectorSell16,870$2.59$43,693.30  
6/9/2023Suzanne IldstadDirectorSell25,419$2.46$62,530.74  
6/7/2023Suzanne IldstadDirectorSell75,001$2.39$179,252.39  
6/5/2023Suzanne IldstadDirectorSell7,841$2.52$19,759.32  
6/1/2023Suzanne IldstadDirectorSell15,713$2.56$40,225.28  
4/21/2023Suzanne IldstadDirectorSell15,004$2.35$35,259.40  
4/19/2023Suzanne IldstadDirectorSell21,753$2.16$46,986.48  
4/17/2023Suzanne IldstadDirectorSell99,771$2.14$213,509.94  
3/17/2023Suzanne IldstadDirectorSell10,436$2.06$21,498.16  
3/1/2023Suzanne IldstadDirectorSell29$2.05$59.45  
2/21/2023Suzanne IldstadDirectorSell3,500$2.05$7,175.00  
2/16/2023Suzanne IldstadDirectorSell2,939$2.06$6,054.34  
8/22/2022Suzanne IldstadInsiderSell525,000$2.80$1,470,000.00  
7/28/2022Scott RequadtCEOBuy3,090$4.25$13,132.50  
7/26/2022Scott RequadtCEOBuy5,528$4.24$23,438.72  
7/22/2022Scott RequadtCEOBuy9,444$3.75$35,415.00  
7/21/2022Francois NaderDirectorBuy36,500$3.72$135,780.00  
7/19/2022Francois NaderDirectorBuy50,000$3.52$176,000.00  
(Data available from 1/1/2013 forward)

TALS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Talaris Therapeutics includes Francois Nader, Scott Requadt, and Suzanne Ildstad. Learn more on insiders at TALS.

16.50% of Talaris Therapeutics stock is owned by insiders. Learn more on TALS's insider holdings.

The following insider sold TALS shares in the last 24 months: Suzanne Ildstad ($708,229.38).

Insiders have sold a total of 307,218 Talaris Therapeutics shares in the last 24 months for a total of $708,229.38 sold.



This page (NASDAQ:TALS) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners